360 related articles for article (PubMed ID: 11928826)
1. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
Anglés-Cano E; Rojas G
Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
[TBL] [Abstract][Full Text] [Related]
2. Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a).
Chitayat S; Kanelis V; Koschinsky ML; Smith SP
Biochemistry; 2007 Feb; 46(7):1732-42. PubMed ID: 17263558
[TBL] [Abstract][Full Text] [Related]
3. A structural assessment of the apo[a] protein of human lipoprotein[a].
Guevara J; Knapp RD; Honda S; Northup SR; Morrisett JD
Proteins; 1992 Feb; 12(2):188-99. PubMed ID: 1318546
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding.
Chenivesse X; Huby T; Wickins J; Chapman J; Thillet J
Biochemistry; 1998 May; 37(20):7213-23. PubMed ID: 9585533
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of fibrinolysis by lipoprotein(a).
Anglés-Cano E; de la Peña Díaz A; Loyau S
Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of apolipoprotein(a) kringle IV37 free and complexed with 6-aminohexanoic acid and with p-aminomethylbenzoic acid: existence of novel and expected binding modes.
Mikol V; LoGrasso PV; Boettcher BR
J Mol Biol; 1996 Mar; 256(4):751-61. PubMed ID: 8642595
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
[TBL] [Abstract][Full Text] [Related]
8. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS
Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375
[TBL] [Abstract][Full Text] [Related]
10. Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance.
Mochalkin I; Cheng B; Klezovitch O; Scanu AM; Tulinsky A
Biochemistry; 1999 Feb; 38(7):1990-8. PubMed ID: 10026282
[TBL] [Abstract][Full Text] [Related]
11. Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10.
Belczewski AR; Ho J; Taylor FB; Boffa MB; Jia Z; Koschinsky ML
Biochemistry; 2005 Jan; 44(2):555-64. PubMed ID: 15641780
[TBL] [Abstract][Full Text] [Related]
12. Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape.
Christen MT; Frank P; Schaller J; Llinás M
Biochemistry; 2010 Aug; 49(33):7131-50. PubMed ID: 20617841
[TBL] [Abstract][Full Text] [Related]
13. The Kringle V-protease domain is a fibrinogen binding region within Apo(a).
Xue S; Madison EL; Miles LA
Thromb Haemost; 2001 Nov; 86(5):1229-37. PubMed ID: 11816712
[TBL] [Abstract][Full Text] [Related]
14. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.
Becker L; Cook PM; Koschinsky ML
Biochemistry; 2004 Aug; 43(31):9978-88. PubMed ID: 15287725
[TBL] [Abstract][Full Text] [Related]
15. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
Gabel BR; Koschinsky ML
Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
[TBL] [Abstract][Full Text] [Related]
16. Definition of the structural elements in plasminogen required for high-affinity binding to apolipoprotein(a): a study utilizing surface plasmon resonance.
Hancock MA; Spencer CA; Koschinsky ML
Biochemistry; 2004 Sep; 43(38):12237-48. PubMed ID: 15379562
[TBL] [Abstract][Full Text] [Related]
17. Lysine/fibrin binding sites of kringles modeled after the structure of kringle 1 of prothrombin.
Tulinsky A; Park CH; Mao B; Llinás M
Proteins; 1988; 3(2):85-96. PubMed ID: 3135547
[TBL] [Abstract][Full Text] [Related]
18. Effect of plasminogen activators on human recombinant apolipoprotein(a) having the plasminogen activation cleavage site.
Hervio L; Brunner C; Sorell L; Kang C; Müller H; Anglés-Cano E
Biochim Biophys Acta; 1999 Sep; 1434(1):124-34. PubMed ID: 10556566
[TBL] [Abstract][Full Text] [Related]
19. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).
Donate LE; Gherardi E; Srinivasan N; Sowdhamini R; Aparicio S; Blundell TL
Protein Sci; 1994 Dec; 3(12):2378-94. PubMed ID: 7756992
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots.
Sangrar W; Koschinsky ML
Biochem Cell Biol; 2000; 78(4):519-25. PubMed ID: 11012092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
